| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1462-5822.2003.00352.X |
| P5875 | ResearchGate publication ID | 229778836 |
| P2093 | author name string | Jens Gieffers | |
| Robert J. Belland | |||
| Gerald I. Byrne | |||
| Scot P. Ouellette | |||
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment | Q31829380 | ||
| Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocyte- derived macrophages | Q37875071 | ||
| Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease | Q37875345 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study | Q37875542 | ||
| Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice | Q37875799 | ||
| Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. | Q37876614 | ||
| Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae | Q37876716 | ||
| Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery | Q37876734 | ||
| Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis | Q37877720 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 | ||
| Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis | Q37878782 | ||
| Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression | Q37880399 | ||
| Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
| Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
| Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group | Q37883953 | ||
| Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells | Q37887085 | ||
| Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries | Q37891287 | ||
| P433 | issue | 2 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 117-127 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Cellular Microbiology | Q1921948 |
| P1476 | title | Chlamydia pneumoniaeand atherosclerosis | |
| P478 | volume | 6 |
| Q37190468 | Antigen-induced immunomodulation in the pathogenesis of atherosclerosis. |
| Q38678102 | Atherosclerosis and aortic aneurysm - is inflammation a common denominator? |
| Q37849872 | Berberine inhibits HEp-2 cell invasion induced by Chlamydophila pneumoniae infection |
| Q37835548 | CCL19-CCR7-dependent reverse transendothelial migration of myeloid cells clears Chlamydia muridarum from the arterial intima |
| Q30389751 | Chlamydia pneumoniae effector chlamydial outer protein N sequesters fructose bisphosphate aldolase A, providing a benefit to bacterial growth |
| Q24311609 | Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways |
| Q37853142 | Chlamydia pneumoniae infection suppresses Staphylococcus enterotoxin B-induced proliferation associated with down-expression of CD25 in lymphocytes |
| Q37847713 | Chlamydial biology and its associated virulence blockers |
| Q37864862 | Chlamydial pathogenesis: diagnostic and therapeutic consequences |
| Q37861559 | Chlamydophila pneumonia: Specific mRNA in aorta ascendens in patients undergoing coronary artery by-pass grafting |
| Q37861802 | Chlamydophila pneumoniae in chronic rhinosinusitis |
| Q34438726 | Cleavage of the NF-κB Family Protein p65/RelA by the Chlamydial Protease-like Activity Factor (CPAF) Impairs Proinflammatory Signaling in Cells Infected with Chlamydiae |
| Q26852204 | Danger signaling in atherosclerosis |
| Q33916075 | Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ. |
| Q24805877 | Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study |
| Q46594047 | Lingonberries reduce atherosclerosis in Apoe(-/-) mice in association with altered gut microbiota composition and improved lipid profile |
| Q39203697 | Microbiota, Immune Subversion, and Chronic Inflammation |
| Q37864592 | MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia |
| Q37860176 | MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae |
| Q39887953 | Number of teeth as a predictor of cardiovascular mortality in a cohort of 7,674 subjects followed for 12 years |
| Q50083304 | R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells |
| Q36322949 | Recent insights into the mechanisms of Chlamydia entry |
| Q34314450 | TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life. |
| Q33429029 | The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection |
| Q36283735 | Therapeutic approaches to Chlamydia infections |
| Q36673413 | Transcription factor complex AP-1 mediates inflammation initiated by Chlamydia pneumoniae infection. |
Search more.